238 related articles for article (PubMed ID: 34247148)
1. Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma.
Mao R; Liu K; Zhao N; Guo P; Wu Y; Wang Z; Liu Y; Zhang T
Aging (Albany NY); 2021 Jul; 13(13):17734-17767. PubMed ID: 34247148
[TBL] [Abstract][Full Text] [Related]
2. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
3. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis Reveals Prognostic Significance of the Macrophage Marker Gene Signature in Gastric Adenocarcinoma.
Li Z; Chen H; Chen Z; Xie L; Pan D
Front Biosci (Landmark Ed); 2024 May; 29(5):172. PubMed ID: 38812299
[TBL] [Abstract][Full Text] [Related]
5. Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
Zhao R; Zhao L; Xu X; Xu H
Oncol Rep; 2019 May; 41(5):2775-2789. PubMed ID: 30864737
[TBL] [Abstract][Full Text] [Related]
6. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
7. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma.
Zhang C; Zhang G; Sun N; Zhang Z; Zhang Z; Luo Y; Che Y; Xue Q; He J
EBioMedicine; 2020 Sep; 59():102959. PubMed ID: 32853987
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.
Zhang C; Zhang Z; Zhang G; Zhang Z; Luo Y; Wang F; Wang S; Che Y; Zeng Q; Sun N; He J
Cancer Lett; 2020 Jun; 479():31-41. PubMed ID: 32201203
[TBL] [Abstract][Full Text] [Related]
10. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma.
Mao R; Yang F; Wang Z; Xu C; Liu Q; Liu Y; Zhang T
Front Cell Dev Biol; 2021; 9():625212. PubMed ID: 33732694
[TBL] [Abstract][Full Text] [Related]
12. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
13. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
Front Immunol; 2021; 12():769685. PubMed ID: 35003085
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
15. Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma.
Zhu Y; Zhao Y; Cao Z; Chen Z; Pan W
Gene; 2022 Apr; 818():146177. PubMed ID: 35065254
[TBL] [Abstract][Full Text] [Related]
16. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
[TBL] [Abstract][Full Text] [Related]
17. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma.
Pasini FS; Zilberstein B; Snitcovsky I; Roela RA; Mangone FR; Ribeiro U; Nonogaki S; Brito GC; Callegari GD; Cecconello I; Alves VA; Eluf-Neto J; Chammas R; Federico MH
J Gastroenterol; 2014 Nov; 49(11):1453-66. PubMed ID: 24217965
[TBL] [Abstract][Full Text] [Related]
18. MiR-96-5p inhibition induces cell apoptosis in gastric adenocarcinoma.
Zhou HY; Wu CQ; Bi EX
World J Gastroenterol; 2019 Dec; 25(47):6823-6834. PubMed ID: 31885423
[TBL] [Abstract][Full Text] [Related]
19. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics.
He X; Chen X; Yang C; Wang W; Sun H; Wang J; Fu J; Dong H
PeerJ; 2024; 12():e16951. PubMed ID: 38436027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
